首页> 美国卫生研究院文献>Oncotarget >RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cells
【2h】

RanBPM (RanBP9) regulates mouse c-Kit receptor level and is essential for normal development of bone marrow progenitor cells

机译:RanBPM(RanBP9)调节小鼠c-Kit受体水平对于骨髓祖细胞的正常发育至关重要

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

c-Kit is a tyrosine kinase receptor important for gametogenesis, hematopoiesis, melanogenesis and mast cell biology. Dysregulation of c-Kit function is oncogenic and its expression in the stem cell niche of a number of tissues has underlined its relevance for regenerative medicine and hematopoietic stem cell biology. Yet, very little is known about the mechanisms that control c-Kit protein levels. Here we show that the RanBPM/RanBP9 scaffold protein binds to c-Kit and is necessary for normal c-Kit protein expression in the mouse testis and subset lineages of the hematopoietic system. RanBPM deletion causes a reduction in c-Kit protein but not its mRNA suggesting a posttranslational mechanism. This regulation is specific to the c-Kit receptor since RanBPM reduction does not affect other membrane proteins examined. Importantly, in both mouse hematopoietic system and testis, RanBPM deficiency causes defects consistent with c-Kit loss of expression suggesting that RanBPM is an important regulator of c-Kit function. The finding that this regulatory mechanism is also present in human cells expressing endogenous RanBPM and c-Kit suggests a potential new strategy to target oncogenic c-Kit in malignancies.
机译:c-Kit是酪氨酸激酶受体,对配子发生,造血,黑色素生成和肥大细胞生物学很重要。 c-Kit功能的异常调节是致癌的,其在许多组织的干细胞小生境中的表达突显了其与再生医学和造血干细胞生物学的相关性。然而,关于控制c-Kit蛋白水平的机制知之甚少。在这里,我们显示RanBPM / RanBP9支架蛋白与c-Kit结合,并且对于小鼠睾丸和造血系统子集的正常c-Kit蛋白表达是必需的。 RanBPM缺失会导致c-Kit蛋白减少,但不会降低其mRNA,提示翻译后机制。由于RanBPM的降低不会影响所检查的其他膜蛋白,因此该调节对c-Kit受体具有特异性。重要的是,在小鼠造血系统和睾丸中,RanBPM缺乏都会导致与c-Kit表达缺失相一致的缺陷,这表明RanBPM是c-Kit功能的重要调节剂。在表达内源性RanBPM和c-Kit的人类细胞中也存在这种调节机制的发现表明,针对恶性肿瘤中致癌的c-Kit的潜在新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号